immatics biotechnologies GmbH (IMTXW) NASDAQ

0.00

-0.0046(-88.46%)

Updated at June 30 04:00PM

Currency In USD

Valuation

Market Cap746.35M
Enterprise Value525.8M
P/E Ratio-12.72
PEG Ratio0.04
Price/Sales Ratio7.23
Price/Book Ratio2.02
Enterprise/Revenue5.39
Enterprise/EBITDA-12.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.57
Operating Margin-0.67

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.15

Income Statement

Revenue155.84M
Revenue/Share1.07
Gross Profit155.84M
EBITDA34.46M
Net Income15.22M
Diluted EPS0.14

Balance Sheet

Total Cash478.19M
Total Cash/Share3.93
Total Debt17.12M
Total Debt/Equity0.04
Current Ratio8.8
Book Value Per Share3.82

Price History

52-Week Change-99.98
52-Week High0.01
52-Week Low0
Moving Average 50 Days0.02
Moving Average 200 Days0.71

Statistics

Average Volume28,784
Shares Outstanding121.54M
% Held by Institutions3.08

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A